Search by Drug Name or NDC
NDC 47781-0200-50 Melphalan 2 mg/1 Details
Melphalan 2 mg/1
Melphalan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alvogen Inc.. The primary component is MELPHALAN.
MedlinePlus Drug Summary
Melphalan is used to treat multiple myeloma (a type of cancer of the bone marrow). Melphalan is also used to treat a certain type of ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed). Melphalan is in a class of medications called alkylating agents. It works by stopping or slowing the growth of cancer cells in your body.
Related Packages: 47781-0200-50Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Melphalan
Product Information
| NDC | 47781-0200 |
|---|---|
| Product ID | 47781-200_07bf6eb3-d646-e207-7c43-034774e094ce |
| Associated GPIs | 21101040000305 |
| GCN Sequence Number | 008773 |
| GCN Sequence Number Description | melphalan TABLET 2 MG ORAL |
| HIC3 | V1A |
| HIC3 Description | ANTINEOPLASTIC - ALKYLATING AGENTS |
| GCN | 38380 |
| HICL Sequence Number | 007845 |
| HICL Sequence Number Description | MELPHALAN |
| Brand/Generic | Generic |
| Proprietary Name | Melphalan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Melphalan USP, 2 mg |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/1 |
| Substance Name | MELPHALAN |
| Labeler Name | Alvogen Inc. |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207809 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 47781-0200-50 (47781020050)
| NDC Package Code | 47781-200-50 |
|---|---|
| Billing NDC | 47781020050 |
| Package | 50 TABLET in 1 BOTTLE, GLASS (47781-200-50) |
| Marketing Start Date | 2017-03-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |